About Medlinker
Medlinker is a company based in Chengdu (China) founded in 2014 by Wang Shirui. It operates as a On-Demand Services, AI-as-a-Service, and HealthTech. Medlinker has raised $841.52 million across 6 funding rounds from investors including Tencent, China Renaissance Group and Sino Biopharmaceutical. Medlinker offers products and services including Future Doctor App and MedGPT. Medlinker operates in a competitive market with competitors including Verily, Wellframe, Memora Health, MD Revolution and AllyAlign, among others.
- Headquarter Chengdu, China
- Founders Wang Shirui
- Stage Decacorn
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
- Legal Name Chengdu Medcloud Technology Co., Ltd.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$841.52 M (USD)
in 6 rounds
-
Latest Funding Round
$514 M (USD), Series E
Dec 13, 2021
-
Investors
Tencent
& 5 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Medlinker
Medlinker offers a comprehensive portfolio of products and services, including Future Doctor App and MedGPT.
Online consultation platform connecting patients with expert doctors.
AI tool assisting doctors with diagnostic efficiency.
Funding Insights of Medlinker
Medlinker has successfully raised a total of $841.52M across 6 strategic funding rounds. The most recent funding activity was a Series E round of $514 million completed in December 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Medlinker
Medlinker has secured backing from 6 investors, including institutional and venture fund investors. Prominent investors backing the company include Tencent, China Renaissance Group and Sino Biopharmaceutical.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
M&A advisory, asset management firm, and private equity fund focused on multiple sectors
|
Locked | Locked | Locked | |
|
Private equity investments are managed by Yunfeng Capital in China.
|
Locked | Locked | Locked | |
|
Generics for cardio-cerebral diseases and hepatitis are developed and manufactured.
|
Locked | Locked | Locked |
Investor details for Medlinker
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Medlinker
Investment portfolio details for Medlinker
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Medlinker
Detailed financials for Medlinker
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Medlinker Comparisons
Peer comparison for Medlinker
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Medlinker
Medlinker operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Verily, Wellframe, Memora Health, MD Revolution and AllyAlign, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
AI-based solutions for health management are provided.
|
|
| Locked | Locked | Locked |
Mobile and AI-based platform offering support to providers for better patient engagement
|
|
| Locked | Locked | Locked |
Mobile messaging platform is utilized for chronic disease management.
|
|
| Locked | Locked | Locked |
Predictive analytics SaaS platform for patient engagement is provided.
|
|
| Locked | Locked | Locked |
Cloud-based platform for long-term care coordination is provided.
|
Detailed competitors of Medlinker
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Medlinker
Complete news archive for Medlinker
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Medlinker
Medlinker was founded in 2014 and raised its 1st funding round 1 year after it was founded.
Medlinker is headquartered in Chengdu, China. It is registered at Chengdu, Sichuan, China.
Wang Shirui is the current CEO of Medlinker. They have also founded this company.
Medlinker is a funded company, having raised a total of $841.52M across 6 funding rounds to date.
A digital health platform is operated by Medlinker, connecting patients with renowned doctors from top hospitals in China for free online consultations. Services are offered across 26 clinical disciplines and over 100 subspecialties, covering more than 30,000 diseases. AI tools like MedGPT are utilized to assist doctors in diagnostics, while ensuring all advice is reviewed by real clinicians. The platform is focused on making premium medical resources accessible, promoting rational medical practices, and avoiding over-treatment. Solutions are tailored for common ailments and select specialized conditions, supported by extensive medical data and clinical guidelines.
Medlinker's top competitors include Verily, Memora Health and Wellframe.
Medlinker offers Future Doctor App and MedGPT.
Medlinker has 6 investors. Key investors include Tencent, China Renaissance Group, Sino Biopharmaceutical, HongShan, and China Electronic Corporation.
The valuation of Medlinker is $25B as of Dec 2021.